非抗铜绿假单胞菌抗生素体外暴露可诱导铜绿假单胞菌对抗铜绿假单胞菌抗生素耐药
该研究将三株铜绿假单胞菌(ATCC 27853及两株血流分离株)在亚抑菌浓度(1/3基线MIC)的厄他培南、头孢曲松或莫西沙星中连续传代14天,发现抗铜绿假单胞菌抗生素MIC可重复升高,且在不含抗生素恢复3天后(第14天)仍持续存在,全基因组测序揭示外排调控基因和β-内酰胺酶调控基因的趋同突变。
要点
- 亚抑菌浓度非抗铜绿假单胞菌抗生素暴露可筛选出可遗传的多药耐药表型。
- 厄他培南使美罗培南MIC最高升高29倍,头孢曲松使头孢他啶MIC最高升高31倍。
- 耐药升高在撤药后仍持续,突变集中于外排及AmpC调控通路。
核心结论
- 无内在抗铜绿假单胞菌活性的抗生素在亚抑菌浓度下暴露,可重复筛选出铜绿假单胞菌的可遗传多药耐药表型。
- 耐药相关趋同突变出现在经典与直接抗铜绿假单胞菌抗生素压力相关的调控基因中,提示耐药架构可在无靶点结合情况下被选择。
研究设计与样本
- 三株铜绿假单胞菌(ATCC 27853和两株血流分离株)在厄他培南、头孢曲松或莫西沙星三分之一基线MIC存在下连续传代14天。
- 在系列时间点及第14天无抗生素恢复3天后测定美罗培南、头孢他啶、环丙沙星的MIC,并进行纵向全基因组测序鉴定突变。
主要发现
- 厄他培南暴露使美罗培南MIC最高升高29倍。
- 头孢曲松暴露使头孢他啶MIC最高升高31倍。
- 莫西沙星暴露使环丙沙星MIC最高升高12倍。
- 第14天无进一步抗生素压力下升高的MIC仍持续。
- 基因组分析显示外排调控基因(nfxB、nalC、nalD、amrR)和β-内酰胺酶调控基因dacB发生趋同进化突变,出现于MIC升高期间并定位于调控外排和AmpC表达的调控通路。
临床怎么用
- 临床选用无抗铜绿假单胞菌活性的抗生素时,需考虑其可能对铜绿假单胞菌产生附带选择压力。
- 对曾暴露于此类抗生素的患者,应警惕铜绿假单胞菌对美罗培南、头孢他啶、环丙沙星等抗铜绿假单胞菌抗生素的MIC升高。
局限性
- 研究仅纳入三株铜绿假单胞菌(ATCC 27853和两株血流分离株),体外连续传代模型。
- 暴露药物仅限厄他培南、头孢曲松和莫西沙星,浓度为三分之一基线MIC。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pseudomonas aeruginosa readily evolves antimicrobial resistance through regulatory plasticity and stress-adaptive pathways. Clinically, antibiotics lacking intrinsic antipseudomonal activity are often favoured with the assumption that they avoid selective pressure on P. aeruginosa. Whether subinhibitory exposure to such 'non-antipseudomonal antibiotics' (NAPA) can nevertheless select for canonical resistance pathways remains incompletely defined. METHODS: Three P. aeruginosa strains (ATCC 27853 and two bloodstream isolates) were serially passaged over 14 days in the presence of ertapenem, ceftriaxone or moxifloxacin at one-third the baseline MIC. MICs for antipseudomonal antibiotics (meropenem, ceftazidime, ciprofloxacin) were measured at serial time points and after a 3-day antibiotic-free recovery (Day 14). Whole-genome sequencing was performed longitudinally to identify mutations. RESULTS: NAPA exposure led to reproducible elevations in antipseudomonal MICs: ertapenem triggered up to a 29-fold increase in meropenem MIC, ceftriaxone up to a 31-fold rise in ceftazidime MIC and moxifloxacin up to a 12-fold increase in ciprofloxacin MIC. Elevated MICs persisted on Day 14 despite absence of further antibiotic pressure. Genomic analysis revealed convergent evolution of mutations in efflux regulator genes (nfxB, nalC, nalD, amrR) and the β-lactamase-regulating gene dacB, emerging during periods of MIC escalation and mapping to regulatory pathways governing efflux and AmpC expression. CONCLUSIONS: Subinhibitory exposure to antibiotics without intrinsic antipseudomonal activity reproducibly selected for heritable multidrug-resistant phenotypes in P. aeruginosa. Convergent mutations arose in regulatory genes classically associated with direct antipseudomonal antibiotic pressure, demonstrating that resistance architectures can be selected independent of target engagement and underscoring the potential for collateral resistance under antibiotic stress.
引用
- Lasry D, Harrison LB, Bamba R, et al. In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA). J Antimicrob Chemother. 2026. PMID: 42219900. doi:10.1093/jac/dkag182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。